Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Pharmazz Inc. has 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are handled by 4 distinct examiners. Every examiner is assigned to a pending action, indicating that each matter is under the review of a different person.
These examiners are spread across 3 distinct art units. BERHANE, SELAM is the busiest examiner with 1 pending office action. This workload of 1 action is one of the 4 pending office actions. The use of 3 distinct art units for 4 actions shows a concentration of technical subject matter within the USPTO administrative structure.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §102 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERHANE, SELAM | 1 | 58.4% | +56.7% |
| D' AMBROSIO, THEA | 1 | 55.3% | +56.1% |
| YOUNG, MICAH PAUL | 1 | 55.1% | +30.0% |
| BOWLES, DAVID PAUL | 1 | 72.7% | +22.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18478528 | LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND METHOD FOR PREPARATION THEREOF | D' AMBROSIO, THEA | — |
| 18146396 | COMPOSITION AND METHOD FOR WOUND HEALING AND REPAIR OF DAMAGED NERVES | BOWLES, DAVID PAUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19433400 | LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND A PROCESS FOR PREPARATION | BERHANE, SELAM | — |
| 18478528 | LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND METHOD FOR PREPARATION THEREOF | D' AMBROSIO, THEA | — |
| 18317360 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS | YOUNG, MICAH PAUL | — |
| 18146396 | COMPOSITION AND METHOD FOR WOUND HEALING AND REPAIR OF DAMAGED NERVES | BOWLES, DAVID PAUL | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1675 | 1 |
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19433400 | LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND A PROCESS FOR PREPARATION | BERHANE, SELAM | 1675 | §102 | Non-Final OA | — | Pending | Dec 26, 2025 |
| 18478528 | LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND METHOD FOR PREPARATION THEREOF | D' AMBROSIO, THEA | 1654 | §103§112Other | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18317360 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS | YOUNG, MICAH PAUL | 1618 | §103 | Non-Final OA | — | Pending | May 15, 2023 |
| 18146396 | COMPOSITION AND METHOD FOR WOUND HEALING AND REPAIR OF DAMAGED NERVES | BOWLES, DAVID PAUL | 1654 | §103§112 | Final Rejection | — | Pending | Dec 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial